Advertisement
Singapore markets open in 5 hours 3 minutes

  • Straits Times Index

    3,322.62
    +14.72 (+0.45%)
     

  • S&P 500

    5,265.41
    -41.60 (-0.78%)
     

  • Dow

    39,049.92
    -621.12 (-1.57%)
     

  • Nasdaq

    16,726.06
    -75.48 (-0.45%)
     

  • Bitcoin USD

    67,248.91
    -2,506.17 (-3.59%)
     

  • CMC Crypto 200

    1,466.03
    -36.63 (-2.44%)
     

  • FTSE 100

    8,339.23
    -31.10 (-0.37%)
     

  • Gold

    2,333.60
    -59.30 (-2.48%)
     

  • Crude Oil

    76.82
    -0.75 (-0.97%)
     

  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     

  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     

  • Hang Seng

    18,868.71
    -326.89 (-1.70%)
     

  • FTSE Bursa Malaysia

    1,629.18
    +7.09 (+0.44%)
     

  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     

  • PSE Index

    6,659.99
    +52.77 (+0.80%)
     

AstraZeneca wins two approval recommendations from EU agency

Reuters
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York

(Reuters) - The European medicines watchdog has recommended approving AstraZeneca Plc's <AZN.L> treatments for a form of heart failure and a lung disorder, the British drugmaker said on Monday.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Forxiga for treating a form of heart failure and Trixeo Aerosphere for a form of lung disorder known as "smoker's lung".

(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Aditya Soni)